Search results for ''

RICT 2018

4 – 6 July, 2018

Strasbourg, France

ENYO Pharma is proud to announce that a Poster made with Inventiva and Rachel Nechushtai from Hebrew University of Jerusalem will be presented at the 54th edition of the International Conference on Medicinal Chemistry (RICT 2018) in Strasbourg, France on July 4-6, 2018.

RICT will focus on “Interfacing Chemical Biology and Drug Discovery”. The 3-day international congress offers the opportunity to ENYO Pharma to present a novel virus-inspired approach to discover first-in-class preclinical assets for a wide range of therapeutic areas.

Read more »

LaBiotech – French Biotech Raises €40M to Fight Hepatitis B and NASH

https://labiotech.eu/enyo-pharma-hepatitis-nas

BioCentury – ENYO aims for Phase II HBV, NASH trials with €40m round

https://www.biocentury.com/bc-extra/financial-news/2018-06-04/enyo-aims-phase-ii-hbv-nash-trials-%E2%82%AC40m-round

Le Journal des Entreprises – Levée de fonds record de 40 millions d’euros pour Enyo Pharma

https://www.lejournaldesentreprises.com/lyon-saint-etienne-grenoble/article/levee-de-fonds-record-de-40-millions-deuros-pour-enyo-pharma-123561

Les Echos – Enyo Pharma mobilise 40 millions contre l’hépatite B et la NASH

https://www.lesechos.fr/pme-regions/innovateurs/0301751138430-enyo-pharma-mobilise-40-millions-contre-lhepatite-b-et-la-nash-2181141.php